* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Savella contains the active ingredient milnacipran. It is a prescription medication used to manage fibromyalgia in adults.
Fibromyalgia is a long-term condition that affects the way the brain and nervous system process pain. It can make ordinary sensations feel unusually painful and may cause widespread discomfort throughout the body.
Savella may help reduce pain and improve physical function in some people. However, it does not cure fibromyalgia, and its benefits can vary from person to person. Savella is not approved for use in children.
Fibromyalgia commonly causes widespread pain or tenderness affecting both sides of the body and areas above and below the waist. The pain may be described as aching, burning, throbbing, or soreness.
Other symptoms may include fatigue, unrefreshing sleep, morning stiffness, headaches, difficulty concentrating, and increased sensitivity to touch, temperature, light, or sound.
Symptoms may become worse during periods of stress, poor sleep, illness, weather changes, or physical overexertion. The type and severity of symptoms can also change from one day to another.
Savella is used to manage the symptoms of fibromyalgia. Its main purpose is to reduce pain and help improve a person’s ability to complete daily activities.
Some people may notice improvements in physical function, such as being able to walk, exercise, work, or complete household activities more comfortably.
Savella may not improve every fibromyalgia symptom. For example, its effect on fatigue, sleep, or concentration can differ between individuals. Your healthcare provider will assess whether the medication is providing enough benefit to continue treatment.
Savella belongs to a group of medications called serotonin-norepinephrine reuptake inhibitors, commonly known as SNRIs.
Serotonin and norepinephrine are natural chemical messengers used by the brain and nervous system. They are involved in several body functions, including the regulation of pain signals.
After these chemical messengers carry a signal between nerve cells, they are normally taken back up into the cells. Savella slows this reabsorption process, allowing serotonin and norepinephrine to remain active for longer.
This may strengthen the nerve pathways that help reduce or control pain signals. As a result, the nervous system may become less sensitive to pain over time.
The exact way Savella improves fibromyalgia is not fully understood. Its benefit is believed to come from changing how pain signals are processed rather than directly treating inflammation in the muscles or joints.
Savella works in a similar way to medications used to treat depression because it affects serotonin and norepinephrine. However, Savella is approved in the United States for the management of fibromyalgia, not for the treatment of depression.
Having fibromyalgia does not mean that the pain is imaginary or caused only by a mood condition. Fibromyalgia involves real changes in how the nervous system processes pain.
Some people with fibromyalgia also experience depression or anxiety. These conditions may require separate evaluation and treatment.
When Savella is effective, it may help reduce the overall intensity of fibromyalgia pain and make physical activities easier to perform.
Possible improvements may include less widespread pain, reduced tenderness, increased ability to move or exercise, and better participation in everyday activities.
Not everyone responds to Savella. Your healthcare provider may review your pain level, physical function, side effects, and overall quality of life to decide whether the medication is helping.
Savella does not usually provide immediate pain relief. Some people may begin noticing improvement within the first few weeks, but it may take longer to determine its full benefit.
The medication is normally started at a low dose and gradually increased. This allows the body to adjust and may reduce side effects such as nausea, dizziness, sweating, or headache.
Continue taking Savella exactly as prescribed while your healthcare provider evaluates your response. Do not increase the dose or stop treatment on your own.
Savella is usually one part of a complete fibromyalgia-management plan. Medication alone may not control every symptom.
Your healthcare provider may also recommend gentle aerobic exercise, stretching, strength training, improved sleep habits, pacing daily activities, stress management, or physical therapy.
Regular movement is often helpful, but activities should usually begin slowly and increase gradually. Doing too much at once may temporarily worsen pain and fatigue.
Savella affects serotonin and norepinephrine throughout the body, so it may cause effects beyond pain control. Possible side effects include nausea, constipation, headache, increased sweating, dizziness, a faster heart rate, or increased blood pressure.
Because Savella works similarly to some antidepressants, patients should also be monitored for unusual mood or behaviour changes, particularly when treatment begins or the dose changes. Savella carries a boxed warning about suicidal thoughts and behaviours associated with antidepressant-type medications in children, adolescents, and young adults, although Savella itself is not approved for pediatric use.
Take Savella exactly as prescribed and attend follow-up appointments so your healthcare provider can monitor your symptoms, blood pressure, heart rate, side effects, and overall response to treatment.
Savella contains the active ingredient milnacipran. It is available as a tablet taken by mouth and is usually taken twice daily after the starting dose has been gradually increased.
Savella may be taken with or without food. However, taking it with food may help reduce nausea, stomach discomfort, and other digestive side effects.
Take each dose at approximately the same times every day. Many people take one dose in the morning and one in the evening, but you should follow the exact schedule provided by your healthcare provider.
Do not take more Savella, take it more frequently, or change your dose without medical guidance.
Savella is normally started at a low dose and increased over the first week. This gradual increase is called titration.
Titration allows your body time to adjust to the medication and may reduce side effects such as nausea, dizziness, headache, sweating, constipation, increased heart rate, or elevated blood pressure.
The original statement that treatment involves one tablet on the first day and two tablets every day afterward is incomplete. The number of tablets depends on their strength and the stage of the dosing schedule.
The usual titration schedule for adults with fibromyalgia is:
The usual recommended maintenance dose is 50 mg twice daily.
Your healthcare provider may use a slower titration schedule if you are sensitive to side effects. Do not move to the next dose unless instructed.
If the usual maintenance dose does not provide enough relief and the medication is well tolerated, your healthcare provider may increase the dose to 100 mg twice daily.
This equals a maximum total dose of 200 mg per day. Doses above 200 mg per day have not been adequately studied.
A higher dose is not appropriate for everyone and may increase the likelihood of side effects. Your healthcare provider will consider how much the medication is helping, how well you tolerate it, and whether you have other medical conditions.
Your dose may be influenced by:
The goal is to find the lowest dose that provides meaningful symptom relief with manageable side effects.
The kidneys remove much of milnacipran from the body, so kidney function can affect the appropriate dose.
People with mild kidney impairment generally do not require a dosage adjustment. Savella should be used cautiously in people with moderate kidney impairment.
For severe kidney impairment, defined as an estimated creatinine clearance of 5 to 29 mL/min, the usual maintenance dose should be reduced by half to 25 mg twice daily. Depending on the response, it may be increased to a maximum of 50 mg twice daily.
Savella is not recommended for people with end-stage kidney disease.
Take the missed dose when you remember unless it is almost time for your next scheduled dose.
If your next dose is approaching, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time or take extra medication to make up for a missed dose.
Contact your healthcare provider or pharmacist if you miss several doses because you may need guidance before restarting at your previous dosage.
Nausea is a common side effect, particularly when treatment begins or the dose is increased. Taking Savella with food may make it easier to tolerate.
Eating smaller meals, staying hydrated, and following the gradual titration schedule may also help. Contact your healthcare provider if nausea is severe, persistent, or prevents you from eating, drinking, or taking the medication.
Do not reduce the dose or stop treatment on your own.
Savella may increase blood pressure or heart rate. Your healthcare provider may check both before treatment begins and periodically while you take the medication.
Tell your healthcare provider if you have high blood pressure, heart disease, an irregular heartbeat, kidney disease, liver disease, glaucoma, seizures, or difficulty urinating.
Your healthcare provider will also assess whether Savella is meaningfully improving your pain and ability to function. Treatment may be reconsidered if there is little benefit or the side effects outweigh the improvement.
Do not suddenly stop taking Savella unless urgent medical care is required. Abrupt discontinuation may cause withdrawal symptoms such as dizziness, headache, nausea, anxiety, irritability, tiredness, sleep problems, or unusual sensations.
When treatment is no longer needed, your healthcare provider will usually reduce the dose gradually. The tapering schedule will depend on your current dose, how long you have taken Savella, and how you respond as the dose is lowered.
Take Savella exactly as prescribed and at consistent times each day. Taking it with food may help reduce stomach-related side effects.
Do not increase the dose because your symptoms have not improved immediately. It may take several weeks to determine how well Savella is working.
Contact your healthcare provider if you experience severe side effects, a significant increase in blood pressure or heart rate, unusual mood or behavioural changes, or symptoms that do not improve with continued treatment.
Savella (Milnacipran) is available in the following forms and strength:
Older adults may be more likely to develop hyponatremia, which means the sodium level in the blood becomes too low. The risk may be higher in people who take diuretics, also called water pills, or who are dehydrated.
Symptoms of low sodium may include headache, confusion, difficulty concentrating, weakness, unsteadiness, or memory problems. Severe cases may cause seizures or loss of consciousness.
Older adults are also more likely to have reduced kidney function. Because the kidneys remove milnacipran from the body, kidney impairment may increase medication levels and the risk of side effects. A lower dose may be needed in people with severe kidney impairment.
Savella may cause withdrawal symptoms if it is stopped suddenly, especially after regular or long-term use.
Possible withdrawal symptoms include dizziness, headache, nausea, anxiety, irritability, tiredness, sleep problems, mood changes, and unusual sensations.
Do not stop Savella or reduce your dose without speaking with your healthcare provider. When treatment is no longer needed, the dose is usually lowered gradually to reduce the risk of withdrawal symptoms.
Savella carries a boxed warning about an increased risk of suicidal thoughts and behaviours associated with antidepressant-type medications in children, adolescents, and young adults. Savella is not approved for use in children.
Patients, family members, and caregivers should watch for new or worsening depression, suicidal thoughts, severe anxiety, agitation, unusual behaviour, or sudden mood changes, especially when treatment begins or the dose changes.
Contact a healthcare provider promptly if these changes occur. Seek emergency help if there is an immediate risk of self-harm.
Savella has been associated with liver injury, including rare cases of serious liver problems. Tell your healthcare provider if you have liver disease or regularly drink alcohol before starting treatment.
Savella should be used cautiously in people with significant liver impairment. Your healthcare provider will decide whether the medication is appropriate and may monitor your liver function during treatment.
Contact your healthcare provider promptly if you develop yellowing of the skin or eyes, dark urine, severe tiredness, persistent nausea, itching, or pain in the upper-right side of the abdomen.
Savella can interact with other medications. Before starting treatment, tell your healthcare provider and pharmacist about every prescription medication, over-the-counter product, vitamin, and herbal supplement you take.
Special caution is needed with other medications that increase serotonin, including certain antidepressants, tramadol, lithium, triptans used for migraines, buspirone, amphetamines, and St. John’s wort. Combining these products may increase the risk of serotonin syndrome.
Savella should not be taken with a monoamine oxidase inhibitor, also called an MAOI, or within the required waiting period before or after using one. Other medications may increase the risk of bleeding, high blood pressure, a fast heart rate, or difficulty urinating.
Do not start, stop, or change another medication without first checking with your healthcare provider or pharmacist.
Savella may increase blood pressure and heart rate. Your healthcare provider should check both before treatment begins and periodically while you take the medication.
Tell your healthcare provider if you already have high blood pressure, heart disease, an irregular heartbeat, or another cardiovascular condition. Existing high blood pressure should be controlled before treatment begins.
Contact your healthcare provider if you notice a persistent racing or pounding heartbeat, chest discomfort, severe headache, dizziness, or a significant increase in your blood-pressure readings.
Savella may cause dizziness or affect your alertness, judgment, coordination, and ability to react quickly. Some people may also feel tired or drowsy.
Do not drive, operate machinery, or perform potentially dangerous activities until you know how Savella affects you.
Alcohol and other medications that cause drowsiness may worsen these effects. Stand up slowly if you feel dizzy or lightheaded, and contact your healthcare provider if these symptoms are severe or persistent.
Take Savella exactly as prescribed and attend all recommended follow-up appointments. Your healthcare provider may monitor your blood pressure, heart rate, kidney function, liver health, mood, and overall response to treatment.
Seek medical attention promptly for suicidal thoughts, severe confusion, seizures, signs of liver injury, a dangerously fast heartbeat, or symptoms of serotonin syndrome such as agitation, fever, heavy sweating, muscle stiffness, diarrhea, or poor coordination.
Savella contains milnacipran, a serotonin-norepinephrine reuptake inhibitor, commonly called an SNRI. It increases the activity of serotonin and norepinephrine, which are natural chemical messengers involved in how the brain and nervous system process pain. By strengthening these signals, Savella may help reduce abnormal pain sensitivity and improve physical function in people with fibromyalgia. The exact way Savella controls fibromyalgia symptoms is not fully understood. It is believed to change how pain signals are processed rather than directly reducing inflammation in the muscles or joints.
Savella does not usually provide immediate pain relief. Some people may notice improvements within the first few weeks, but it may take several weeks or longer to determine its full benefit. The dose is normally increased gradually during the first week, so your body has time to adjust. Take Savella consistently as prescribed, even if you do not notice an immediate improvement. Your healthcare provider will assess whether the medication is meaningfully reducing pain or improving your ability to complete daily activities. Contact them if your symptoms do not improve or become worse.
Yes. Savella is FDA-approved for the management of fibromyalgia in adults. It is not approved in the United States to treat depression, even though it works similarly to certain antidepressant medications. Savella is not approved for use in children because its safety and effectiveness have not been established in pediatric patients.
Yes. Suddenly stopping Savella may cause withdrawal symptoms, particularly after regular or long-term treatment. Possible symptoms may include nausea, headache, dizziness, tiredness, anxiety, irritability, sleep problems, mood changes, or unusual sensations. Do not stop Savella or reduce your dose without medical guidance. When treatment is no longer needed, your healthcare provider will usually lower the dose gradually to reduce the risk of withdrawal symptoms.
| Generic name: | Milnacipran |
|---|---|
| Formulation: | Capsule, Tablet |
| Strength(s): | 25mg, 50mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Savella (milnacipran) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is beneficial for managing chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Savella is commonly prescribed in dosages of 25 mg or 50 mg, taken twice daily. For a 90-day supply, you would order 180 tablets (90 days x 2 tablets per day).
Yes, we sell milnacipran on our website, and you can enjoy competitive prices. To purchase milnacipran, you will need a valid prescription from your healthcare provider. We require this to ensure the safe and appropriate dispensing of medication. You can conveniently submit your prescription by mail, fax, or upload it through your online account to streamline the ordering process.
Yes, we ship Savella (milnacipran) to both the United States and Puerto Rico.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Savella (Milnacipran). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Savella (Milnacipran).
REVIEWS